Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Methotrexate's effectiveness for maintaining hair regrowth in alopecia totalis is unclear due to limited and biased data.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

MitoQ helps protect hair cells from damage in hair loss by boosting a protective enzyme.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Metformin can help prevent the side effects of glucocorticoid medications on metabolism.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Retinoids might cause temporary hyperthyroidism in some patients.

Alopecia is a key indicator of thallium poisoning.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Selenium in proteins helps prevent over-oxidation and supports chemical reversibility.

Removing the thymoma improved the man's autoimmune conditions.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.